タイロートロピンの高い親和性を持つ甲状腺のギャングリオシド: 甲状腺の調節における潜在的な役割

B R Mullin¹, T Pacuszka, G Lee

¹Laboratory of Biochemical Pharmacology, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, MD 20014, USA.

Science (New York, N.Y.)

|January 6, 1978

まとめ

甲状腺細胞膜には,チロトロピン結合を阻害するギャングリオシドが含まれています. 微量に存在する新種のギャングリオシドは,ホルモンシグナル伝達における役割を示唆する最も強力な阻害剤です.

科学分野:

エンドクリノロジーエンドクリノロジー
細胞生物学細胞生物学
グライコバイオロジーは,

背景:

甲状腺細胞膜には,様々なギャングリオシドがあります.
いくつかのギャングリオシドは,チロトロピン (TSH) 受容体相互作用を調節する.
甲状腺ホルモンの調節におけるギャングリオシドの正確な役割は完全に理解されていません.

研究の目的:

甲状腺細胞膜のギャングリオシドを特定し,特徴づけること.
タイロトロピン結合に対するこれらのギャングリオシドの抑制効果を調査する.
ホルモン信号伝達における甲状腺のギャングリオシドの潜在的役割を調査する.

主な方法:

甲状腺細胞膜からのギャングリオシドの分離と浄化.
甲状腺膜へのタイロトロピンの結合を測定するアッセイ.
特定されたギャングリオシドの構造分析.

主要な成果:

甲状腺細胞膜に複数のギャングリオシドが同定されました.
いくつかのギャングリオシドは,チロトロピン結合に対する抑制活性を示した.
微量で見つかった新種のギャングリオシドが,最も強力な抑制作用を示した.
この強力な阻害剤は,ユニークな構造構成を有しています.

結論:

甲状腺のギャングリオシド,特に新しい強力な阻害剤は,甲状腺膜へのチロトロピンの結合を大幅に阻害することができます.
これらの発見は,特定のギャングリオシドが,甲状腺細胞のチロトロピンに対する反応を調節する上で重要な役割を果たすことを示唆しています.
甲状腺のギャングリオシドは,甲状腺細胞内のホルモンメッセージのリレーにおける重要な調節体として機能する可能性があります.

さらに関連する動画

06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

関連する概念動画

01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...

01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...

01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...

01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

関連する実験動画